CD40 and neoplasm: We found that tumor endothelial cells from agonistic CD40 mAb treated tumors upregulated biological processes such as “inflammatory response”, “response to IFNγ”, “positive regulation of leukocyte chemotaxis” and “positive regulation of TNF production”.